Vitamin D can fight Covid-19: Vicctori trial's interim results

It is an inexpensive thing that people should be aware of, says UHS VC Prof. Dr Javed Akram

LAHORE:

The interim results of the Vicctori trial (Vitamin D in Covid Cytokine storm therapy on registered inpatients) were released on Monday by the Vice-Chancellor University of Health Sciences (UHS) Lahore and President Pakistan Society of Internal Medicine, Prof. Dr Javed Akram

Announcing the results, the UHS VC said: “We have conclusively shown through our trial that Vitamin D not only protects you from the (Covid-19) virus but also prevents further progression of the disease”.

“Vitamin D is an inexpensive thing that people should be aware of,” he further added.

Read more: Covid-19: give me fresh air to breathe, please!

The results were released at the first UHS International conference on Covid-19, in the presence of Chief Guest Governor Punjab Chaudry Muhammad Sarwar, Justice (retd) Tassaduq Hussain Jilani, and CEO DRAP (Drug Regulatory Authority of Pakistan) Asim Rauf.

The Vicctori trial, which was initiated in June 2020 by UHS and Scotmann Pharmaceuticals, has shown promising improvement in the Covid-19 patients after Vitamin D therapy (SunnyD) was added as an adjunct to the conventional Covid-19 therapy.